InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,473.17
(
-0.25%
)
US TECH 100
19,288.80
(
-0.62%
)
Dow Jones
39,134.76
(
0.77%
)
Brent Oil
85.04
(
0.04%
)
Bitcoin
64,560.96
(
-0.40%
)
Post# of 647743
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Covid19freak

Send PM Follow Ignore
Followers 10
Posts 1251
Boards Moderated 0
Alias Born 07/20/2020

Covid19freak

Re: None

Monday, 05/22/2023 3:24:45 PM

Monday, May 22, 2023 3:24:45 PM

Post# of 647743
ATHA $2.90- Alzheimer P2/3 data in Q1 ..stock trading 50% under cash balance


"The company expects topline data from its Phase 2/3 LIFT-AD study in mild-to-moderate Alzheimer’s disease in early 2024.
An independent data monitoring committee recommended continuing the study in patients with mild-to-moderate Alzheimer’s in October after an unblinded interim efficacy and futility analysis."
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up